FdaNdcDirectoryPulse / compare
BRYTLY vs Lidocaine Pain Relief Gel-Patch: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and Lidocaine Pain Relief Gel-Patch (2026-10-14) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to Lidocaine Pain Relief Gel-Patch?
| Field | BRYTLY | Lidocaine Pain Relief Gel-Patch |
|---|---|---|
| Product | BRYTLY | Lidocaine Pain Relief Gel-Patch |
| Generic name | Apraclonidine Hydrochloride | Lidocaine |
| NDC | 0065-8596 | 87918-160 |
| Labeler | Alcon Laboratories, Inc. | Guangzhou Dachuang International Trade Co., Ltd |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | OTC MONOGRAPH DRUG |
| Application number | NDA220341 | 505G(a)(3) |
| Dosage form | SOLUTION/ DROPS | PATCH |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | LIDOCAINE .04 g/g |
| Marketing start | 2026-10-16 | 2026-10-14 |
| Package configurations | 3 | 10 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · Lidocaine Pain Relief Gel-Patch
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.